Home
>
US Stocks
>
Annovis Bio Inc
Annovis Bio Inc
ANVS

Annovis Bio Inc (ANVS)

$29.2718.65%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
$28.52
Today Low/High
$28.52 / $29.4
52 Week Low/High
$4.14 / $132
Market Cap
$308.96M

Company Details

Headquartered in Berwyn, Pennsylvania, Annovis Bio, Inc. (Annovis) is a clinical-stage, drug platform company addressing neurodegeneration, such as Alzheimer's disease (AD), Parkinson's disease (PD) and Alzheimer's in Down Syndrome (AD-DS). The Comapny's believes that it is the only company developing a drug for AD, PD and AD-DS that inhibits more than one neurotoxic protein and, thereby, improves the information highway of the nerve cell, known as axonal transport. When this information flow is impaired, the nerve cell gets sick and dies. The Company expects its treatment to improve memory loss and dementia associated with AD and AD-DS, as well as body and brain function in PD. The Company has two ongoing Phase 2a studies: one in AD patients and one in both AD and PD patients.
Organisation
Annovis Bio Inc
Headquaters
Berwyn, Pennsylvania, US
Employees
2
Industry
Electronic Equipment/Instruments
CEO
Maria Maccecchini

Discover more

Frequently Asked Questions

What is Annovis Bio Inc (ANVS) share price today?

Can Indians buy Annovis Bio Inc (ANVS) shares?

How can I buy Annovis Bio Inc (ANVS) shares from India?

Can Fractional shares of Annovis Bio Inc (ANVS) be purchased?

What are the documents required to start investing in Annovis Bio Inc (ANVS) stocks?

We are a SEBI registered investement advisor